TABLE 1

Demographics and Clinical Characteristics

VariableControl (n = 57)Clinical Pathway (n = 56)
Age (y), median (IQR)5.1 (3.5–8.5)4.7 (3.5–7.8)
Children <2 y of age, n (%)2 (4)0 (0)
Sex (male), n (%)31 (54)39 (70)
Approximate annual household income before tax, n (%)
 <$20 0002 (4)1 (2)
 $20 000–$36 9991 (2)4 (7)
 $37 000–$49 9992 (4)3 (5)
 $50 000–$74 9999 (16)6 (11)
 >$75 00036 (63)29 (52)
 Do not know3 (5)4 (7)
 Prefer not to answer4 (7)9 (16)
Highest completed education of primary child-care provider, n (%)
 Elementary school2 (4)2 (4)
 High school15 (26)7 (13)
 College diploma18 (32)16 (29)
 University degree22 (39)31 (55)
Primary child-care provider in the household, n (%)
 Mother50 (88)52 (93)
 Father7 (12)4 (7)
Child was admitted from, n (%)
 ICU3 (5)2 (4)
 Clinic0 (0)0 (0)
 ED49 (86)50 (89)
 Home0 (0)0 (0)
 Other5 (9)3 (5.4)
Child’s PRAM score on arrival at ED, median (IQR)8.0 (7.0–9.0)9.0 (7.0–10.0)
Asthma-related ED visits in past 12 mo, median (IQR)2.0 (1.0–2.0)2.0 (1.0–3.0)
Asthma-related hospital admissions in past 12 mo, median (IQR)1.0 (1.0–1.0)1.0 (1.0–2.0)
Child has a history of prematurity (<37 wk GA), n (%)7 (12)8 (14)
Received magnesium sulfate in the ED, n (%)31 (54)26 (46)
Oxygen dependence on admission, n (%)26 (46)25 (46)
Child has concurrent bacterial pneumonia, n (%)13 (23)8 (14)
Child has concurrent viral illness, n (%)50 (88)47 (84)
Child was on home asthma therapy before admission, n (%)42 (74)43 (77)
History of mechanical ventilation for asthma, n (%)1 (2)2 (4)
History of previous admissions to an ICU for asthma, n (%)3 (5)7 (13)
Smokers in the primary place of residence, n (%)17 (30)10 (18)
Pets in the primary place of residence, n (%)35 (61)34 (61)
Child received the following medications in the ED, n (%)
 Salbutamol56 (98)55 (98)
 Ipratropium bromide46 (81)45 (80)
  • GA, gestational age.